Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Biology
|
January 15, 2010
Chromosome analysis of the differential radiosensitivity of an Epstein-Barr virus (EBV)-transformed B cell line and B and T lymphocytes from the same blood donor
Ernst Schmid, Hartmut Roos, Wiebke Sauter, et al.
British Journal of Clinical Pharmacology
|
September 19, 2024
A randomized phase I study of the safety and pharmacokinetics of BI 1291583 in healthy Japanese male subjects
Yusuke Tadayasu, Donald Sarubbi, Takumi Furuichi, et al.
Genes
|
April 8, 2014
Heritability of radiation response in lung cancer families
Albert Rosenberger, Ute Rössler, Sabine Hornhardt, et al.
Clinical Biochemistry
|
January 24, 2009
A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers
Maria Timofeeva, Birgit Jäger, Albert Rosenberger, et al.
DNA Repair
|
January 18, 2011
Validation of a fully automated COMET assay: 1.75 million single cells measured over a 5 year period
Albert Rosenberger, Ute Rössler, Sabine Hornhardt, et al.
ERJ Open Research
|
March 26, 2024
The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583
James D Chalmers, Philipp Badorrek, Claudia Diefenbach, et al.
DNA Repair
|
March 29, 2014
Genetic factors in individual radiation sensitivity
Sabine Hornhardt, Ute Rößler, Wiebke Sauter, et al.
Scientific Reports
|
May 24, 2022
An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP)
Ilaria Campo, Federica Meloni, Martina Gahlemann, et al.
Clinical and Experimental Rheumatology
|
July 1, 2017
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)
Oliver Distler, Kevin K Brown, Jörg H W Distler, et al.
ERJ Open Research
|
July 19, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf
James D Chalmers, Abhya Gupta, Sanjay H Chotirmall, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Biology
|
January 15, 2010
Chromosome analysis of the differential radiosensitivity of an Epstein-Barr virus (EBV)-transformed B cell line and B and T lymphocytes from the same blood donor
Ernst Schmid, Hartmut Roos, Wiebke Sauter, et al.
British Journal of Clinical Pharmacology
|
September 19, 2024
A randomized phase I study of the safety and pharmacokinetics of BI 1291583 in healthy Japanese male subjects
Yusuke Tadayasu, Donald Sarubbi, Takumi Furuichi, et al.
Genes
|
April 8, 2014
Heritability of radiation response in lung cancer families
Albert Rosenberger, Ute Rössler, Sabine Hornhardt, et al.
Clinical Biochemistry
|
January 24, 2009
A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers
Maria Timofeeva, Birgit Jäger, Albert Rosenberger, et al.
DNA Repair
|
January 18, 2011
Validation of a fully automated COMET assay: 1.75 million single cells measured over a 5 year period
Albert Rosenberger, Ute Rössler, Sabine Hornhardt, et al.
ERJ Open Research
|
March 26, 2024
The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583
James D Chalmers, Philipp Badorrek, Claudia Diefenbach, et al.
DNA Repair
|
March 29, 2014
Genetic factors in individual radiation sensitivity
Sabine Hornhardt, Ute Rößler, Wiebke Sauter, et al.
Scientific Reports
|
May 24, 2022
An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP)
Ilaria Campo, Federica Meloni, Martina Gahlemann, et al.
Clinical and Experimental Rheumatology
|
July 1, 2017
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)
Oliver Distler, Kevin K Brown, Jörg H W Distler, et al.
ERJ Open Research
|
July 19, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf
James D Chalmers, Abhya Gupta, Sanjay H Chotirmall, et al.
Page
of 3